Advertisement

Overproduction of Nitric Oxide in Physiology and Pathophysiology: EPR Detection

  • Yann A. Henry
Chapter

Abstract

Stimulating developments in current research on the biological roles of NO are the immediate implications to physiology and pathophysiology, both in animal models and in humans.1–3 Many diseases have been related to overproduction or underproduction of NO by NOS isoenzymes. The use of NO-donors, such as organic nitrates, nitroprusside or molsidomines, has in fact largely preceded the discovery of EDRF/NO and is quite well monitored (see chapter 12). The use of NO gas and that of NOS inhibitors have been under careful trial for several diseases since 1990. We shall limit the evocation of NO-related pathophysiology in animal models and in humans to a miscellaneous and restricted number of cases in which EPR spectroscopy has made some contribution to the estimation or quantification of NO: cancer, infections and septic shock, autoimmune diseases, organ transplantations and a few other cases in which NOS II induction occurs. Whenever possible we shall focus on human pathologies. Due to the low sensitivity of EPR spectroscopy, most of the cases of detection derive from NO synthesized by inducible NOS in a long-term process which allows NO accumulation on metalloprotein targets. Several selective reviews have been published on this subject.4–9

Keywords

Nitric Oxide Cerebral Malaria Experimental Allergic Encephalomyelitis Nitric Oxide Synthesis Endotoxic Shock 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109–142.PubMedGoogle Scholar
  2. 2.
    Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6:3051–3064.PubMedGoogle Scholar
  3. 3.
    Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995; 9:1319–1330.PubMedGoogle Scholar
  4. 4.
    Henry Y, Ducrocq C, Drapier J-C et al. Nitric oxide, a biological effector. Electron paramagnetic resonance detection of nitrosyl-iron-protein complexes in whole cells. Eur Biophys J 1991; 20:1–15.PubMedCrossRefGoogle Scholar
  5. 5.
    Henry Y, Lepoivre M, Drapier J-C et al. EPR characterisation of molecular targets for NO in mammalian cells and organelles. FASEB J 1993; 7:1124–1134.PubMedGoogle Scholar
  6. 6.
    Wilcox DE, Smith RP. Detection and quantification of nitric oxide using electron magnetic resonance spectroscopy. Methods: a companion to Methods in Enzymology 1995; 7:59–70.CrossRefGoogle Scholar
  7. 7.
    Henry YA, Singel DJ. Metal-nitrosyl interactions in nitric oxide biology probed by electron paramagnetic resonance spectroscopy. In: Feelisch M, Stamler JS. Methods in Nitric Oxide Research. John Wiley & Sons, 1996:357–372.Google Scholar
  8. 8.
    Singel DJ, Lancaster JR. Electron paramagnetic resonance spectroscopy and nitric oxide biology. In: Feelisch M, Stamler JS. Methods in Nitric Oxide Research. John Wiley & Sons, 1996:341–356.Google Scholar
  9. 9.
    Kosaka H, Shiga T. Detection of nitric oxide by electron paramagnetic resonance using hemoglobin. In: Feelisch M, Stamler JS. Methods in Nitric Oxide Research. John Wiley & Sons, 1996:373–381.Google Scholar
  10. 10.
    Förstermann U, Schmidt HHHW, Pollock JS et al. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 1991; 42:1849–1857.PubMedCrossRefGoogle Scholar
  11. 11.
    Nathan C, Xie Q. Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78:915–918.PubMedCrossRefGoogle Scholar
  12. 12.
    Kishimoto J, Spurr N, Liao M et al. Localization of brain nitric oxide synthase to human chromosome 12. Genomics 1992; 14:802–804.PubMedCrossRefGoogle Scholar
  13. 13.
    Marsden PA, Schappert KT, Chen HS et al. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett 1992; 307:287–293.PubMedCrossRefGoogle Scholar
  14. 14.
    Marsden PA, Heng HHQ, Scherer SW et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268:17478–17488.PubMedGoogle Scholar
  15. 15.
    Nadaud S, Bonnardeaux A, Lathrop M et al. Gene structure, polymorphism and mapping of the human endothelial nitric oxide gene. Biochem Biophys Res Commun 1994; 198:1027–1033.PubMedCrossRefGoogle Scholar
  16. 16.
    Robinson LJ, Weremowicz S, Morton CC et al. Isolation and chromosomal localization of the human endothelial nitric oxide synyhase (NOS3) gene. Genomics 1994; 19:350–357.PubMedCrossRefGoogle Scholar
  17. 17.
    Miyahara K, Kawamoto T, Sase K et al. Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur J Biochem 1994; 223:719–726.PubMedCrossRefGoogle Scholar
  18. 18.
    Janssens SP, Shimouchi A, Quertermous T et al. Cloning and expression of the cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992; 267:14519–14522.PubMedGoogle Scholar
  19. 19.
    Tsukahara H, Gordienko DV, Goligorsky MS. Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells. Biochem Biophys Res Commun 1993; 193:722–729.PubMedCrossRefGoogle Scholar
  20. 20.
    Sato I, Morita I, Kaji K et al. Reduction of nitric oxide producing activity associated with in vitro aging in cultured human umbilical vein endothelial cell. Biochem Biophys Res Commun 1993; 195:1070–1076.PubMedCrossRefGoogle Scholar
  21. 21.
    Schmidt HHHW, Murad F. Purification and characterization of a human NO synthase. Biochem Biophys Res Commun 1991; 181:1372–1377.PubMedCrossRefGoogle Scholar
  22. 22.
    Klatt P, Heinzel B, Mayer B et al. Stimulation of human nitric oxide synthase by tetrahydrobiopterin and selective binding of the cofactor. FEBS Lett 1992; 305:160–162.PubMedCrossRefGoogle Scholar
  23. 23.
    Pickard RS, Powell PH, Zar MA. The effect of inhibitors of nitric oxide biosynthesis and cyclic GMP formation on nerve-evoked relaxation of human cavernosal smooth muscle. Br J Pharmacol 1991; 104:755–759.PubMedGoogle Scholar
  24. 24.
    Nakane M, Schmidt HHHW, Pollock JS et al. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 1993; 316:175–180.PubMedCrossRefGoogle Scholar
  25. 25.
    Conrad KP, Joffe GM, Kruszyna H et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993; 7:566–571.PubMedGoogle Scholar
  26. 26.
    Conrad KP, Vill M, McGuire PG et al. Expression of nitric oxide synthase by syncytiotrophoblast in human placental villi. FASEB J 1993; 7:1269–1276.PubMedGoogle Scholar
  27. 27.
    Garvey EP, Tuttle JV, Covington K et al. Purification and characterization of the constitutive nitric oxide synthase from human placenta. Arch Biochem Biophys 1994; 311:235–241.PubMedCrossRefGoogle Scholar
  28. 28.
    Chartrain NA, Geller DA, Koty PP et al. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem 1994; 269:6765–6772.PubMedGoogle Scholar
  29. 29.
    Marsden PA, Heng HHQ, Duff CL et al. Localization of the human gene for inducible nitric oxide synthase (NOS2) to chromosome 17q11.2-ql2. Genomics 1994; 19:183–185.PubMedCrossRefGoogle Scholar
  30. 30.
    Sparrow JR. Inducible nitric oxide synthase in the central nervous system. J Molec Neurosci 1995; 5:219–229.CrossRefGoogle Scholar
  31. 31.
    Gustafsson LE, Leone AM, Persson MG et al. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991; 181:852–857.PubMedCrossRefGoogle Scholar
  32. 32.
    Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium; killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leuk Biol 1991; 49:380–387.Google Scholar
  33. 33.
    Denis M. Human monocytes/macrophages: NO or no NO? J Leuk Biol 1994; 55:682–684.Google Scholar
  34. 34.
    Kolb JP, Paul-Eugène N, Damais C et al. Interleukin-4 stimulates cGMP production by IFN-γ-activated human monocytes. Involvement of the nitric oxide synthase pathway. J Biol Chem 1994; 269:9811–9816.PubMedGoogle Scholar
  35. 35.
    Dumarey CH, Labrousse V, Rastogi N et al. Selective Mycobacterium avium-induced production of nitric oxide by human monocytes-derived macrophages. J Leuk Biol 1994; 56:36–40.Google Scholar
  36. 36.
    Zembala M, Siedlar M, Marcinkiewicz J et al. Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide. Eur J Immunol 1994; 24:435–439.PubMedCrossRefGoogle Scholar
  37. 37.
    Paul-Eugène N, Mossalayi D, Sarfati M et al. Evidence for a role of FcεRII/CD23 in the IL-4-induced nitric oxide production by normal human mononuclear phagocytes. Cell Immunol 1995; 163:314–318.PubMedCrossRefGoogle Scholar
  38. 38.
    Dugas B, Mossalayi MD, Damais C et al. Nitric oxide production by human monocytes: evidence for a role of CD23. Immunol Today 1995; 16:574–580.PubMedCrossRefGoogle Scholar
  39. 39.
    Weinberg JB, Misukonis MA, Shami PJ et al. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 1995; 86:1184–1195.PubMedGoogle Scholar
  40. 40.
    Torre D, Ferrario G, Bonetta G et al. Production of nitric oxide from peripheral blood mononuclear cells and polymorphonuclear leukocytes of patients with HIV-1. AIDS 1995; 9:979–980.PubMedCrossRefGoogle Scholar
  41. 41.
    Albina JE. On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leuk Biol 1995; 58:643–649.Google Scholar
  42. 42.
    Bryant JL, Mehta P, Von der Porten A et al. Co-purification of 130 kD nitric oxide synthase and a 22 kD link protein from human neutrophils. Biochem Biophys Res Commun 1992; 189:558–564.PubMedCrossRefGoogle Scholar
  43. 43.
    Heck DE, Laskin DL, Gardner CR et al. Epidermal growth factor suppresses nitric oxide and peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. J Biol Chem 1992; 267:21277–21280.PubMedGoogle Scholar
  44. 44.
    Nussler AK, Di Silvio M, Billiar TR et al. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med 1992; 176:261–264.PubMedCrossRefGoogle Scholar
  45. 45.
    Stadler J, Bergonia HA, Di Silvio M et al. Nonheme iron-nitrosyl complex formation in rat hepatocytes: detection by electron paramagnetic resonance spectroscopy. Arch Biochem Biophys 1993; 302:4–11.PubMedCrossRefGoogle Scholar
  46. 46.
    Nussler AK, Geller DA, Sweetland MA et al. Induction of nitric oxide synthesis and its reactions in cultured human and rat hepatocytes stimulated with cytokines plus LPS. Biochem Biophys Res Commun 1993; 194:826–835.PubMedCrossRefGoogle Scholar
  47. 47.
    Geller DA, Lowenstein CJ, Shapiro RA et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 1993; 90:3491–3495.PubMedCrossRefGoogle Scholar
  48. 48.
    Nussler AK, Di Silvio M, Liu Z-Z et al. Further characterization and comparison of inducible nitric oxide synthase in mouse, rat, and human hepatocytes. Hepatology 1995; 21:1552–1560.PubMedGoogle Scholar
  49. 49.
    Stadler J, Stefanovic-Racic M, Billiar TR et al. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 1991; 147:3915–3920.PubMedGoogle Scholar
  50. 50.
    Palmer RMJ, Hickery MS, Charles IG et al. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun 1993; 193:398–405.PubMedCrossRefGoogle Scholar
  51. 51.
    Häuselmann HJ, Oppliger L, Michel BA et al. Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture. FEBS Lett 1994; 352:361–364.PubMedCrossRefGoogle Scholar
  52. 52.
    Nicolson AG, Haites NE, McKay NG et al. Induction of nitric oxide synthase in human mesangial cells. Biochem Biophys Res Commun 1993; 193:1269–1274.PubMedCrossRefGoogle Scholar
  53. 53.
    Mollace V, Colasanti M, Rodino P et al. Cytokine-induced nitric oxide generation by cultured astrocytoma cells involve a Ca++-calmodulin-independent NO-synthase. Biochem Biophys Res Commun 1993; 191:327–334.PubMedCrossRefGoogle Scholar
  54. 54.
    Hu S, Sheng WS, Peterson PK et al. Differential regulation by cytokines of human astrocyte nitric oxide production. Glia 1995; 15:491–494.PubMedCrossRefGoogle Scholar
  55. 55.
    Kasai K, Hattori Y, Nakanishi N et al. Regulation of inducible nitric oxide production by cytokines in human thyrocytes in culture. Endocrinol 1995; 136:4261–4270.CrossRefGoogle Scholar
  56. 56.
    Corbett JA, Sweetland MA, Wang JL et al. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci USA 1993; 90:1731–1735.PubMedCrossRefGoogle Scholar
  57. 57.
    Adcock IM, Brown CR, Kwon O et al. Oxidative stress induces NFkB DNA binding and inducible NOS mRNA in human epithelial cells. Biochem Biophys Res Commun 1994; 199:1518–1524.PubMedCrossRefGoogle Scholar
  58. 58.
    Robbins RA, Barnes PJ, Springall DR et al. Expression of inducible nitric oxide in human lung epithelial cells. Biochem Biophys Res Commun 1994; 203:209–218.PubMedCrossRefGoogle Scholar
  59. 59.
    Goureau O, Hicks D, Courtois Y. Human retinal pigmented epithelial cells produce nitric oxide in response to cytokines. Biochem Biophys Res Commun 1994; 198:120–126.PubMedCrossRefGoogle Scholar
  60. 60.
    Ralston SH, Todd D, Helfrich M et al. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 1994; 135:330–336.PubMedCrossRefGoogle Scholar
  61. 61.
    Rabinovitch A, Suarez-Pinzon W, Strynadka K et al. Human pancreatic islet β-cell destruction by cytokines is independent of nitric oxide production. J Clin Endocrinol Metab 1994; 79:1058–1062.PubMedCrossRefGoogle Scholar
  62. 62.
    Welsh N, Eizirik DL, Sandler S. Nitric oxide and pancreatic β-cell destruction in insulin dependent diabetes mellitus: don’t take NO for an answer. Autoimmunity 1994; 18:285–290.PubMedCrossRefGoogle Scholar
  63. 63.
    Maruyama T, Kataoka N, Nagase S et al. Identification of three-line electron spin resonance signal and its relationship to ascites tumors. Cancer Res 1971; 31:179–184.PubMedGoogle Scholar
  64. 64.
    Vithayathil AJ, Ternberg JL, Commoner B. Changes in electron spin resonance signals of rat liver during chemical carcinogenesis. Nature 1965; 207:1246–1249.PubMedCrossRefGoogle Scholar
  65. 65.
    Vanin AF, Vakhnina LV, Chetverikov AG. Nature of the EPR signals of a new type found in cancer tissues. Biofizika 1970; 15:1044–1051 (English translation 1082–1089).Google Scholar
  66. 66.
    Bastian NR, Yim CY, Hibbs JB et al. Induction of iron-derived EPR signals in murine cancers by nitric oxide. Evidence for multiple intracellular targets. J Biol Chem 1994; 269:5127–5131.PubMedGoogle Scholar
  67. 67.
    Yim C-Y, Bastian NR, Smith JC et al. Macrophage nitric oxide synthesis delays progression of ultraviolet light-induced murine skin cancers. Cancer Res 1993; 53:5507–5511.PubMedGoogle Scholar
  68. 68.
    Jenkins DC, Charles IG, Thomsen LL et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995; 92:4392–4396.PubMedCrossRefGoogle Scholar
  69. 69.
    Miwa M, Stuehr DJ, Marietta et al. Nitrosation of amines by stimulated macrophages. Carcinogenesis 1987; 7:955–958.CrossRefGoogle Scholar
  70. 70.
    Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48:3554–3560.PubMedGoogle Scholar
  71. 71.
    Bartsch H, Ohshima H, Pignatelli B. Inhibitors of endogenous nitrosation mechanisms and implications in human cancer prevention. Mutation Res 1988; 202:307–324.PubMedCrossRefGoogle Scholar
  72. 72.
    Ohshima H, Tsuda M, Adachi H et al. L-arginine-dependent formation of N-nitrosamines by the cytosol of macrophages activated with lipopolysaccharide and interferon-γ. Carcinogenesis 1991; 12:1217–1220.PubMedCrossRefGoogle Scholar
  73. 73.
    Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutation Res 1994; 305:253–264.PubMedCrossRefGoogle Scholar
  74. 74.
    Thomsen LL, Lawton FG, Knowles RG et al. Nitric oxide synthase activity in human gynecological cancer. Cancer Res 1994; 54:1352–1354.PubMedGoogle Scholar
  75. 75.
    Thomsen LL, Miles DW, Happerfield L et al. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995; 72:41–44.PubMedCrossRefGoogle Scholar
  76. 76.
    Cobbs CS, Brenman JE, Aldape KD et al. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 1995; 55:727–730.PubMedGoogle Scholar
  77. 77.
    Symons MCR, Rowland IJ, Deighton N et al. Electron spin resonance studies of nitrosyl haemoglobin in human liver, colon and stomach tumour tissues. Free Rad Res Comms 1994; 21:197–202.CrossRefGoogle Scholar
  78. 78.
    Yim C-Y, McGregor JR, Kwon O-D et al. Nitric oxide synthesis contributes to IL-2-induced antitumor responses against intraperitoneal Meth A tumor. J Immunol 1995; 155:4382–4390.PubMedGoogle Scholar
  79. 79.
    Hibbs JB, Westenfelder C, Taintor R et al. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 1992; 89:867–877.PubMedCrossRefGoogle Scholar
  80. 80.
    Lieberman MD, Nishioka K, Redmond P et al. Enhancement of interleukin-2 immunotherapy with L-arginine. Ann Surgery 1992; 215:157–165.CrossRefGoogle Scholar
  81. 81.
    Ochoa JB, Curti B, Peitzman AB et al. Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes. J Natl Cancer Inst 1992; 84:864–867.PubMedCrossRefGoogle Scholar
  82. 82.
    Miles D, Thomsen L, Balkwill F et al. Association between biosynthesis of nitric oxide and changes in immunological and vascular parameters in patients treated with interleukin-2. Eur J Clin Invest 1994; 24:287–290.PubMedCrossRefGoogle Scholar
  83. 83.
    Heiss LN, Lancaster JR, Corbett JA et al. Epithelial autotoxicity of nitric oxide: role in respiratory cytopathology of pertussis. Proc Natl Acad Sci USA 1994; 91:267–270.PubMedCrossRefGoogle Scholar
  84. 84.
    Nussler AK, Billiar TR. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leuk Biol 1993; 54:171–178.Google Scholar
  85. 85.
    Nussler AK, Liu Z-Z, Di Silvio M et al. Hepatocyte inducible nitric oxide synthase is influenced by cell density. Am J Physiol 1994; 266: C394–C401.Google Scholar
  86. 86.
    Billiar TR, Curran RD, Stuehr DJ et al. An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med 1989; 169:1467–1472.PubMedCrossRefGoogle Scholar
  87. 87.
    Curran RD, Billiar TR, Stuehr DJ et al. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med 1989; 170:1769–1774.PubMedCrossRefGoogle Scholar
  88. 88.
    Suzuki H, Menegazzi M, Carcereri de Prati A et al. Nitric oxide in the liver: physiopathological roles. Adv Neuroimmunol 1995; 5:379–410.PubMedCrossRefGoogle Scholar
  89. 89.
    Chamulitrat W, Jordan SJ, Mason RP et al. Targets of nitric oxide in a mouse model of liver inflammation by Corynebacterium parvum. Arch Biochem Biophys 1995; 316:30–37.PubMedCrossRefGoogle Scholar
  90. 90.
    Geller DA, de Vera ME, Russell DA et al. A central role for IL-1β in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. IL-1β induces hepatic nitric oxide synthesis. J Immunol 1995; 155:4890–4898.PubMedGoogle Scholar
  91. 91.
    Rachmilewitz D, Karmeli F, Eliakim R et al. Enhanced gastric nitric oxide activity in duodenal ulcer patients. Gut 1994; 35:1394–1397.PubMedCrossRefGoogle Scholar
  92. 92.
    Clark IA, Rockett KA, Cowden WB. Proposed link between cytokines, nitric oxide and human cerebral malaria. Parasitol Today 1991; 7:205–207.PubMedCrossRefGoogle Scholar
  93. 93.
    Clark IA, Rockett KA. The cytokine theory of human cerebral malaria. Parasitol Today 1994; 10:410–412.PubMedCrossRefGoogle Scholar
  94. 94.
    Cot S, Ringwald P, Mulder B et al. Nitric oxide in cerebral malaria. J Infect Diseases 1994; 169:1417–1418.CrossRefGoogle Scholar
  95. 95.
    Ghigo D, Todde R, Ginsburg H et al. Erythrocyte stages of Plasmodium falciparum exhibit a high nitric oxide synthase (NOS) activity and release an NOS-inducing soluble factor. J Exp Med 1995; 183:677–688.CrossRefGoogle Scholar
  96. 96.
    Asensio V. Neuropaludisme et monoxyde d’azote. PhD doctorate thesis. Université Paris XII-Val de Marne. 1995.Google Scholar
  97. 97.
    Asensio VC, Ohshima H, Falanga PB. Plasmodium berghei: is nitric oxide involved in the pathogenesis of mouse cerebral malaria? Exp Parasitol 1993; 77:111–117.PubMedCrossRefGoogle Scholar
  98. 98.
    Lee SC, Dickson DW, Brosnan CF et al. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J Exp Med 1994; 180:365–369.PubMedCrossRefGoogle Scholar
  99. 99.
    Evans TG, Rasmussen K, Wiebke G et al. Nitric oxide synthesis in patients with advanced HIV infection. Clin Exp Immunol 1994; 97:83–86.PubMedCrossRefGoogle Scholar
  100. 100.
    Bukrinsky MI, Nottet HSLM, Schmidt-mayerova H et al. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 1995; 181:735–745.PubMedCrossRefGoogle Scholar
  101. 101.
    Dighiero P, Reux I, Hauw J-J et al. Expression of inducible nitric oxide synthase in cytomegalovirus-infected glial cells of retinas from AIDS patients. Neurosci Lett 1994; 166:31–34.PubMedCrossRefGoogle Scholar
  102. 102.
    Dal Nogare AR. Southwestern Internal Medicine Conference: Septic shock. Am J Med Sci 1991; 302:50–65.CrossRefGoogle Scholar
  103. 103.
    Stoclet J-C, Fleming I, Gray G et al. Nitric oxide and endotoxemia. Circulation 1993; 87:V77–V80.Google Scholar
  104. 104.
    Redmond HP, Chavin KD, Bromberg JS et al. Inhibition of macrophage-activating cytokines is beneficial in the acute septic response. Ann Surg 1991; 214:502–509.PubMedCrossRefGoogle Scholar
  105. 105.
    Damas P, Ledoux D, Nys M et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992; 215:356–362.PubMedCrossRefGoogle Scholar
  106. 106.
    Kilbourn RG, Jubran A, Gross SS et al. Reversal of endotoxin-mediated shock by N G-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172:1132–1138.PubMedCrossRefGoogle Scholar
  107. 107.
    Hutcheson IR, Whittle BJR, Boughton-Smith NK. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990; 101:815–820.PubMedGoogle Scholar
  108. 108.
    Westenberger U, Thanner S, Ruf HH et al. Formation of free radicals and nitric oxide derivative of hemoglobin in rats during shock syndrome. Free Rad Res Comms 1990; 11:167–178.CrossRefGoogle Scholar
  109. 109.
    Wang Q, Jacobs J, DeLeo J et al. Nitric oxide hemoglobin in mice and rats in endotoxic shock. Life Sci 1991; PL55–PL60.Google Scholar
  110. 110.
    Kosaka H, Watanabe M, Yoshihara H et al. Detection of nitric oxide production in lipopolysaccharide-treated rats by ESR using carbon monoxide hemoglobin. Biochem Biophys Res Commun 1992; 184:1119–1124.PubMedCrossRefGoogle Scholar
  111. 111.
    Kosaka H, Harada N, Watanabe M et al. Synergistic stimulation of nitric oxide hemoglobin production in rats by recombinant interleukin 1 and tumor necrosis factor. Biochem Biophys Res Commun 1992; 189:392–397.PubMedCrossRefGoogle Scholar
  112. 112.
    Beasley D, Eldridge M. Interleukin-1β and tumor necrosis factor-β synergistically induce NO synthase in rat vascular smooth muscle cells. Am J Physiol 1994; 266:R1197–R1203.PubMedGoogle Scholar
  113. 113.
    Kosaka H, Sakaguchi H, Sawai Y et al. Effect of interferon-γ on nitric oxide hemoglobin production in endotoxin-treated rats and its synergism with interleukin 1 or tumor necrosis factor. Life Sci 1994; 54:1523–1529.PubMedCrossRefGoogle Scholar
  114. 114.
    Kubrina LN, Mikoyan VD, Mordvintcev PI et al. Iron potentiates bacterial lipopolysac-charide-induced nitric oxide formation in animal organs. Biochim Biophys Acta 1993; 1176:240–244.PubMedCrossRefGoogle Scholar
  115. 115.
    Kosaka H, Sawai Y, Sakaguchi H et al. ESR spectral transition by arteriovenous cycle in nitric oxide hemoglobin of cytokine-treated rats. Am J Physiol 1994; 266:C1400–1405.PubMedGoogle Scholar
  116. 116.
    Henry Y, Banerjee R. Electron paramagnetic studies of nitric oxide haemoglobin derivatives: isolated subunits and nitric oxide hybrids. J Mol Biol 1973; 73:469–482.PubMedCrossRefGoogle Scholar
  117. 117.
    Henry Y, Cassoly R. Chain non-equivalence in nitric oxide binding to hemoglobin. Biochem Biophys Res Commun 1973; 51:659–665.PubMedCrossRefGoogle Scholar
  118. 118.
    Chamulitrat W, Jordan SJ, Mason RP. Nitric oxide production during endotoxic shock in carbon tetrachloride-treated rats. Mol Pharmacol 1994; 46:391–397.PubMedGoogle Scholar
  119. 119.
    Feder LS, Laskin DL. Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF, and IL-1β following acute endotoxemia. J Leuk Biol 1994; 55:507–513.Google Scholar
  120. 120.
    Hecker M, Schott C, Bucher B et al. Increase in serum N G-hydroxy-L-arginine in rats treated with bacterial lipoplysaccharide. Eur J Pharmacol 1995; 275:R1–R3.PubMedCrossRefGoogle Scholar
  121. 121.
    Szabo C, Southan GJ, Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiurea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 1994; 91:12472–12476.PubMedCrossRefGoogle Scholar
  122. 122.
    Stewart TE, Valenza F, Ribeiro SP et al. Increased nitric oxide in exhaled gas as an early marker of lung inflammation in a model of sepsis. Am J Respir Crit Care Med 1995; 151:713–718.PubMedGoogle Scholar
  123. 123.
    Florquin S, Amraoui Z, Dubois C et al. The protective role of endogenously synthesized nitric oxide in staphyloccal enterotoxin B-induced shock in mice. J Exp Med 1994; 180:1153–1158.PubMedCrossRefGoogle Scholar
  124. 124.
    MacMicking JD, Nathan C, Horn G et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81:641–650.PubMedCrossRefGoogle Scholar
  125. 125.
    Laubach VE, Shesely EG, Smithies O et al. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 1995; 92:10688–10692.PubMedCrossRefGoogle Scholar
  126. 126.
    Ochoa JB, Udekwu AO, Billiar TR et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214:621–626.PubMedCrossRefGoogle Scholar
  127. 127.
    Editorial. Nitric oxide in the clinical arena. Lancet 1991; 338:1560–1562.Google Scholar
  128. 128.
    Nava E, Palmer RMJ, Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 1991; 338:1555–1557.PubMedCrossRefGoogle Scholar
  129. 129.
    Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338:1557–1558.PubMedCrossRefGoogle Scholar
  130. 130.
    Hotchkiss RS, Karl IE, Parker JL et al. Inhibition of NO synthesis in septic shock. Lancet 1992; 339:434–435.PubMedCrossRefGoogle Scholar
  131. 131.
    Geroulanos S, Schilling J, Cakmakci M et al. Inhibition of NO synthesis in septic shock. Lancet 1992; 339:435.PubMedCrossRefGoogle Scholar
  132. 132.
    Cohen J, Silva A. NO inhibitors and septic shock. Lancet 1992; 339:751.PubMedCrossRefGoogle Scholar
  133. 133.
    Berrazueta JR, Salas E, Amado JA et al. Induction of nitric oxide synthase in human mammary arteries in vitro. Eur J Pharmacol 1994; 251:303–305.PubMedCrossRefGoogle Scholar
  134. 134.
    Glauser MP, Heumann D, Baumgartner JD et al. Pathogenesis and potential strategies for prevention and treatment of septic shock: an update. Clin Infect Dis 1994; 18:S205–S216.PubMedCrossRefGoogle Scholar
  135. 135.
    Natanson C, Hoffman WD, Suffredini AF et al. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994; 120:771–783.PubMedGoogle Scholar
  136. 136.
    Barthlen W, Stadler J, Lehn NL et al. Serum levels of end products of nitric oxide synthesis correlate positively with tumor necrosis factor α and negatively with body temperature in patients with postoperative abdominal sepsis. Shock 1994; 2:398–401.PubMedCrossRefGoogle Scholar
  137. 137.
    Vladutiu AO. Role of nitric oxide in autoimmunity. Clinic Immunol Immuno-pathol 1995; 76:1–11.CrossRefGoogle Scholar
  138. 138.
    Boughton-Smith NK, Evans SM, Hawkey CJ et al. Nitric oxide activity in ulcerative colitis and Crohn’s disease. Lancet 1993; 342:338–340PubMedCrossRefGoogle Scholar
  139. 139.
    Tran DD, Visser JJ, Pool MO et al. Enhanced systemic nitric oxide production in inflammatory bowel disease. Lancet 1993; 341:1150.PubMedCrossRefGoogle Scholar
  140. 140.
    Boughton-Smith NK. Pathological and therapeutic implications for nitric oxide in inflammatory bowel disease. J Royal Soc Med 1994; 87:312–313.Google Scholar
  141. 141.
    Lundberg JON, Hellström PM, Lundberg JM et al. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994; 344:1673–1674.PubMedCrossRefGoogle Scholar
  142. 142.
    Lundberg JON, Hellström PM, Lundberg JM et al. Nitric oxide in ulcerative colitis. Lancet 1995; 345:449.CrossRefGoogle Scholar
  143. 143.
    Mourelle M, Casellas F, Guarner F et al. Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon. Gastroenterol 1995; 109:1497–1502.CrossRefGoogle Scholar
  144. 144.
    Rachmilewitz D, Stamler JS, Bachwich D et al. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn’s disease. Gut 1995; 36:718–723.PubMedCrossRefGoogle Scholar
  145. 145.
    Kolb-Bachofen V, Fehsel K, Michel G et al. Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of psoriasis vulgaris. Lancet 1994; 344:139.PubMedCrossRefGoogle Scholar
  146. 146.
    Lipton SA, Choi Y-B, Pan Z-H et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993; 364:626–632.PubMedCrossRefGoogle Scholar
  147. 147.
    Johnson AW, Land JM, Thomson EJ et al. Evidence for increased nitric oxide production in multiple sclerosis. J Neurol 1995; 58:107–115.Google Scholar
  148. 148.
    Bagasra O, Michaels FH, Zheng YM et al. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci USA 1995; 92:12041–12045.PubMedCrossRefGoogle Scholar
  149. 149.
    Smith RS, Maes M. The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. Med Hypotheses 1995; 45:135–141.PubMedCrossRefGoogle Scholar
  150. 150.
    Farrell AJ, Blake DR, Palmer RMJ et al. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992; 51:1219–1222.PubMedCrossRefGoogle Scholar
  151. 151.
    Stefanovic-Racic M, Stadler J, Evans CH. Nitric oxide and arthritis. Arthritis Rheum 1993; 36:1036–1044.PubMedCrossRefGoogle Scholar
  152. 152.
    McCartney-Francis N, Allen JB, Mizel DE et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993; 178:749–754.PubMedCrossRefGoogle Scholar
  153. 153.
    Southern C, Schulster D, Green IC. Inhibition of insulin secretion by interleukin-lβ and tumour necrosis factor-α via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett 1990; 276:42–44.PubMedCrossRefGoogle Scholar
  154. 154.
    Corbett JA, Lancaster JR, Sweetland MA et al. Interleukin-lβ-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. J Biol Chem 1991; 266:21351–21354.PubMedGoogle Scholar
  155. 155.
    Corbett JA, Wang JL, Hughes JH et al. Nitric oxide and cyclic GMP formation induced by interleukin lβ in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. Biochem J 1992; 229–235.Google Scholar
  156. 156.
    Corbett JA, Wang JL, Sweetland MA et al. Interleukin lβ induces the formation of nitric oxide by β-cells purified from rodent islets of Langerhans. Evidence for the β-cell as a source and site of action of nitric oxide. J Clin Invest 1992; 90:2384–2391.PubMedCrossRefGoogle Scholar
  157. 157.
    Bergmann L, Kröncke KD, Suschek C et al. Cytotoxic action of IL-lβ against pancreatic islets is mediated via nitric oxide formation and is inhibited by NG-monomethyl-L-arginine. FEBS Lett 1992; 299:103–106.PubMedCrossRefGoogle Scholar
  158. 158.
    Eizirik DL, Cagliero E, Björklund A et al. Interleukin-lβ induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages. FEBS Lett 1992; 308:249–252.PubMedCrossRefGoogle Scholar
  159. 159.
    Corbett JA, Kwon G, Misko TP et al. Tyrosine kinase involvement in IL-lβ-induced expression of iNOS by β-cells purified from islets of Langerhans. Am J Physiol 1994; 267:C48–54.PubMedGoogle Scholar
  160. 160.
    Yamada K, Otabe S, Inada C et al. Nitric oxide and nitric oxide synthase mRNA induction in mouse islet cells by interferon-γ plus tumor necrosis factor-α. Biochem Biophys Res Commun 1993; 197:22–27.PubMedCrossRefGoogle Scholar
  161. 161.
    Sternesjö J, Bendtzen K, Sandler S. Effects of prolonged exposure in vitro to interferon- γ and tumor necrosis factor-α on nitric oxide and insulin production of rat pancreatic islets. Autoimmunity 1995; 20:185–190.PubMedCrossRefGoogle Scholar
  162. 162.
    Corbett JA, McDaniel ML. Reversibility of interleukin-lβ-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. Biochem J 1994; 299:719–724.PubMedGoogle Scholar
  163. 163.
    Eizirik DL, Sandler S, Welsh N et al. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 1994; 93:1968–1974.PubMedCrossRefGoogle Scholar
  164. 164.
    Mollace V, Nistico G. Release of nitric oxide from astroglial cells: a key mechanism in neuroimmune disorders. Adv Neuroimmunol 1995; 5:421–430.PubMedCrossRefGoogle Scholar
  165. 165.
    Lin RF, Lin T-S, Tilton RG et al. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study. J Exp Med 1993; 178:643–648.PubMedCrossRefGoogle Scholar
  166. 166.
    Hooper DC, Ohnishi ST, Kean R et al. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc Natl Acad Sci USA 1995; 92:5312–5316.PubMedCrossRefGoogle Scholar
  167. 167.
    Scoazec JY, Lesèche G. Immunologie des cellules endothéliales et rejet de greffe. Médecine/Science 1993; 9:1094–1101.Google Scholar
  168. 168.
    Langrehr JM, Hoffman RA, Lancaster JR et al. Nitric oxide — a new endogenous immunomodulator. Transplantation 1993; 55:1205–1212.PubMedCrossRefGoogle Scholar
  169. 169.
    Langrehr JM, Hoffman RA, Billiar TR et al. Nitric oxide synthesis in the in vivo allograft response: a possible regulatory mechanism. Surgery 1991; 110:335–342.PubMedGoogle Scholar
  170. 170.
    Langrehr JM, Dull KE, Ochoa JB et al. Evidence that nitric oxide production by in vivo allosensitized cells inhibits the development of allospecific CTL. Transplantation 1992; 53:632–640.PubMedCrossRefGoogle Scholar
  171. 171.
    Langrehr JM, Müller AR, Bergonia HA et al. Detection of nitric oxide by electron paramagnetic resonance spectroscopy during rejection and graft-versus-host disease after small-bowel transplantation in the rat. Surgery 1992; 112:395–402.PubMedGoogle Scholar
  172. 172.
    Lancaster JR, Langrehr JM, Bergonia HA et al. EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J Biol Chem 1992; 267:10994–10998.PubMedGoogle Scholar
  173. 173.
    Bastian NR, Xu SR, Shao XL et al. Nω-monomethyl-L-arginine inhibits nitric oxide production in murine cardiac allografts but does not affect graft rejection. Biochim Biophys Acta 1994; 1226:225–231.PubMedGoogle Scholar
  174. 174.
    Worrall NK, Lazenby WD, Misko TP et al. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 1995; 181:63–70.PubMedCrossRefGoogle Scholar
  175. 175.
    Yang X, Chowdhury N, Cai B et al. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest 1994; 94:714–721.PubMedCrossRefGoogle Scholar
  176. 176.
    Winlaw DS, Schyvens CG, Smythe GA et al. Urinary nitrate excretion is a noninvasive indicator of acute cardiac allograft rejection and nitric oxide production in the rat. Transplantation 1994; 58:1031–1036.PubMedCrossRefGoogle Scholar
  177. 177.
    Winlaw DS, Schyvens CG, Smythe GA et al. Selective inhibition of nitric oxide production during cardiac allograft rejection causes a small increase in graft survival. Transplantation 1995; 60:77–82.PubMedCrossRefGoogle Scholar
  178. 178.
    Oz MC, Pinsky DJ, Koga S et al. Novel preservation solution permits 24-hour preservation in rat and baboon cardiac transplant models. Circulation 1993; 88:291–297.Google Scholar
  179. 179.
    Pinsky DJ, Naka Y, Chowdhury NC et al. The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. Proc Natl Acad Sci USA 1994; 91:12086–12090.PubMedCrossRefGoogle Scholar
  180. 180.
    Tanaka S, Kamiike W, Ito T et al. Generation of nitric oxide as a rejection marker in rat pancreas transplantation. Transplantation 1995; 60:713–717.PubMedCrossRefGoogle Scholar
  181. 181.
    Ohdan H, Fukuda Y, Suzuki S et al. Simultaneous evaluation of nitric oxide synthesis and tissue oxygenation in rat liver allograft rejection using near-infrared spectroscopy. Transplantation 1995; 60:530–535.PubMedCrossRefGoogle Scholar
  182. 182.
    Devlin J, Palmer RMJ, Gonde CE et al. Nitric oxide generation. A predictive parameter of acute allograft rejection. Transplantation 1994; 58:592–595.PubMedCrossRefGoogle Scholar
  183. 183.
    Ioannidis I, Hellinger A, Dehmlow C et al. Evidence for increased nitric oxide production after liver transplantation in humans. Transplantation 1995; 59:1293–1297.PubMedGoogle Scholar
  184. 184.
    Weiss G, Schwaighoffer H, Herold M et al. Nitric oxide formation as predictive parameter for acute graft-versus-host disease after human allogeneic bone marrow transplantation. Transplantation 1995; 60:1239–1244.PubMedGoogle Scholar
  185. 185.
    Deng MC, Erren M, Kammerling L et al. The relation of interleukin-6, tumor necrosis factor-α, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation. Transplantation 1995; 60:1118–1124.PubMedCrossRefGoogle Scholar
  186. 186.
    Roth E, Steininger R, Winkler S et al. L-arginine deficiency after liver transplantation as an effect of arginase efflux from the graft. Transplantation 1994; 57:665–669.PubMedCrossRefGoogle Scholar
  187. 187.
    Adatia I, Lillehei C, Arnold JH et al. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation. Ann Thorac Surg 1994; 57:1311–1318.PubMedCrossRefGoogle Scholar
  188. 188.
    Wennmalm Å, Lanne B, Petersson A-S. Detection of endothelium-derived factor in human plasma in the basal state and following ischemia using electron paramagnetic resonance spectrometry. Anal Biochem 1990; 187:359–363.PubMedCrossRefGoogle Scholar
  189. 189.
    Geng Y, Petersson A-S, Wennmalm Å et al. Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells. Exp Cell Res 1994; 214:418–428.PubMedCrossRefGoogle Scholar
  190. 190.
    Schulz R, Triggle CR. Role of NO in vascular smooth muscle and cardiac muscle function. Trends in Pharmacol Sci 1994; 15:255–259.CrossRefGoogle Scholar
  191. 191.
    Hansson GK, Geng Y, Holm J et al. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med 1994; 180:733–738.PubMedCrossRefGoogle Scholar
  192. 192.
    Winlaw DS, Smythe GA, Keogh AM et al. Increased nitric oxide production in heart failure. Lancet 1994; 344:373–374.PubMedCrossRefGoogle Scholar
  193. 193.
    Dusting GJ, Macdonald PS. Endogenous nitric oxide in cardiovascular disease and transplantation. Ann Med 1995; 27:395–406.PubMedCrossRefGoogle Scholar
  194. 194.
    Wildhirt SM, Dudek RR, Suzuki H et al. Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction. Int J Cardiol 1995; 50:253–261.PubMedCrossRefGoogle Scholar
  195. 195.
    Zweier JL, Wang P, Samouilov A et al. Enzyme-independent formation of nitric oxide in biological tissues. Nature Medicine 1995; 1:804–809.PubMedCrossRefGoogle Scholar
  196. 196.
    Konorev EA, Joseph J, Kalyanaraman B. S-nitrosoglutathione induces formation of nitrosylmyoglobin in isolated hearts during cardioplegic ischemia. An electron spin resonance study. FEBS Lett 1996; 378:111–114.PubMedCrossRefGoogle Scholar
  197. 197.
    Iadecola C, Pelligrino DA, Moskowitz MA et al. Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 1994; 14:175–192.PubMedCrossRefGoogle Scholar
  198. 198.
    Kumura E, Yoshimine T, Tanaka S et al. Nitrosyl hemoglobin production during reperfusion after focal cerebral ischemia in rats. Neurosci Lett 1994; 177:165–167.PubMedCrossRefGoogle Scholar
  199. 199.
    Dugan LL, Lin TS, He YY et al. Detection of free radicals by microdialysis/spin trapping EPR following focal cerebral ischemia-reperfiision and a cautionary note on the stability of 5,5-dimethyl-1-pyrroline N-oxide (DMPO). Free Rad Res 1995; 23:27–32.CrossRefGoogle Scholar
  200. 200.
    Sato S, Tominaga T, Ohnishi T et al. ESR spin-trapping study of nitric oxide formation during bilateral carotid occlusion in the rat. Biochim Biophys Acta 1993; 195:197.Google Scholar
  201. 201.
    Sato S, Tominaga T, Ohnishi T et al. Electron paramagnetic resonance study on nitric oxide production during brain focal ischemia and reperfusion in the rat. Brain Res 1994; 647:91–96.PubMedCrossRefGoogle Scholar
  202. 202.
    Zhang ZG, Chopp M, Bailey F et al. Nitric oxide changes in the rat brain after transient middle cerebral artery occlusion. J Neurol Sci 1995; 128:22–27.PubMedCrossRefGoogle Scholar
  203. 203.
    Verrechia C, Boulu RG, Plotkine M. Neuroprotective and deleterious effects of nitric oxide on focal cerebral ischemia-induced neurone death. Adv Neuroimmunol 1995; 5:359–378.CrossRefGoogle Scholar
  204. 204.
    Hall DM, Buettner GR, Matthes RD et al. Hyperthermia stimulates nitric oxide formation: electron paramagnetic resonance detection of NO-heme in blood. J Appl Physiol 1994; 77:548–553.PubMedGoogle Scholar
  205. 205.
    Holthusen H, Arndt JO. Nitric oxide evokes pain in humans on intracutaneous injection. Neurosci Lett 1994; 165:71–74.PubMedCrossRefGoogle Scholar
  206. 206.
    Olesen J, Thomsen LL, Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends in Pharmacol Sci 1994;15:149–153.CrossRefGoogle Scholar
  207. 207.
    Brown DR, Schmidt B, Kretzschmar HA. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 1996; 380:345–347.PubMedCrossRefGoogle Scholar
  208. 208.
    McLaughlin MK, Conrad KP. Nitric oxide biosynthesis during pregnancy: implications for circulatory changes. Clin Exp Pharmacol Physiol 1995; 22:164–171.PubMedCrossRefGoogle Scholar
  209. 209.
    Yallampalli C, Izumi H, Byam-Smith M et al. An L-arginine-nitric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy. Am J Obstet Gynecol 1994; 170:175–185.PubMedGoogle Scholar
  210. 210.
    Lees C, Campbell S, Jauniaux E et al. Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. Lancet 1994; 343:1325–1326.PubMedCrossRefGoogle Scholar
  211. 211.
    Participants in the 39th Forum in Immunology. L-arginine-derived nitric oxide and the cell-mediated immune response. Res Immunol 1991; 142:553–602.CrossRefGoogle Scholar
  212. 212.
    Granger DL. Macrophage production of nitrogen oxides in host defence against microorganisms. Res Immunol 1991; 142:570–572.PubMedCrossRefGoogle Scholar

Copyright information

© R.G. Landes Company 1997

Authors and Affiliations

  • Yann A. Henry

There are no affiliations available

Personalised recommendations